Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab. (Record no. 30832560)

MARC details
000 -LEADER
fixed length control field 00864 a2200217 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518094559.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2531-1387
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.htct.2020.02.001
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Ellithi, Moataz
245 00 - TITLE STATEMENT
Title Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Hematology, transfusion and cell therapy
Date of publication, distribution, etc.
300 ## - PHYSICAL DESCRIPTION
Extent 364-367 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Case Reports; Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shahid, Mahum
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Abdullah, Hafez Mohammad
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bleeker, Jonathan
773 0# - HOST ITEM ENTRY
Title Hematology, transfusion and cell therapy
Related parts vol. 43
-- no. 3
-- p. 364-367
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.htct.2020.02.001">https://doi.org/10.1016/j.htct.2020.02.001</a>
Public note Available from publisher's website

No items available.